Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
174 NOK | -6.70% | -3.87% | -18.69% |
Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Apr. 02 | Medistim ASA Proposes Dividend | CI |
Sales 2024 * | 552M 50.38M | Sales 2025 * | 589M 53.74M | Capitalization | 3.42B 311M |
---|---|---|---|---|---|
Net income 2024 * | 112M 10.21M | Net income 2025 * | 124M 11.31M | EV / Sales 2024 * | 6 x |
Net cash position 2024 * | 101M 9.21M | Net cash position 2025 * | 136M 12.4M | EV / Sales 2025 * | 5.56 x |
P/E ratio 2024 * |
30.5
x | P/E ratio 2025 * |
27.5
x | Employees | 151 |
Yield 2024 * |
2.41% | Yield 2025 * |
1.89% | Free-Float | 74.3% |
Latest transcript on Medistim ASA
1 day | -7.24% | ||
1 week | -4.42% | ||
Current month | -6.99% | ||
1 month | -3.08% | ||
3 months | -17.22% | ||
6 months | -6.99% | ||
Current year | -19.16% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 174 | -6.70% | 29 751 |
24-04-24 | 186.5 | +5.07% | 4,654 |
24-04-23 | 177.5 | +0.85% | 4,082 |
24-04-22 | 176 | 0.00% | 7,063 |
24-04-19 | 176 | -2.76% | 3,709 |
Real-time Oslo Bors, April 25, 2024 at 03:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.16% | 311M | |
+8.78% | 220B | |
+8.24% | 185B | |
+11.16% | 133B | |
+26.12% | 107B | |
+0.08% | 62.91B | |
+16.21% | 53.34B | |
-1.63% | 47.71B | |
-1.11% | 40.29B | |
+12.16% | 39.57B |
- Stock Market
- Equities
- MEDI Stock